|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens tumor necrosis factor (TNF superfamily, member 2) DNA.|
|DIF, TNFA, TNFSF2, TNF-alpha, TNF|
|pMD18-T Simple Vector|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
pMD18-T Simple Vector is a high-efficiency TA cloning vector constructed from pUC18, of which the initial multiple cloning sites (MCS) were destroyed. Thus the cDNA should be amplified by PCR with primers containing a restriction site for subclone. Competent cells appropriate for pUC18 are also appropriated for the Vector, e.g. JM109, DH5α, TOP10. The pMD18-T Simple Vector is 2.6kb in size. Selection of the plasmid in E. coli is conferred by the ampicillin resistance gene. The coding sequence was inserted by TA cloning at site 425.
The coding sequence can be amplified by PCR with M13-47 and RV-M primers.
|Human TNFα Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG10602-M-F|
|Human TNFα Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG10602-M-H|
|Human TNFA Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG10602-M-M|
|Human TNFα Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG10602-M-N|
|Human TNFα Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG10602-M-Y|
|Product name||Product name|
Tumor necrosis factor alpha (TNF-alpha), also known as TNF, TNFA or TNFSF2, is the prototypic cytokine of the TNF superfamily, and is a multifunctional molecule involved in the regulation of a wide spectrum of biological processes including cell proliferation, differentiation, apoptosis, lipid metabolism, and coagulation. Two receptors, TNF-R1 (TNF receptor type 1; CD120a; p55/60) and TNF-R2 (TNF receptor type 2; CD120b; p75/80), bind to TNF-alpha. TNF-alpha protein is produced mainly by macrophages, and large amounts of this cytokine are released in response to lipopolysaccharide, other bacterial products, and Interleukin-1 (IL-1). TNF-alpha is involved in fighting against the tumorigenesis, thus, is regarded as a molecular insight in cancer treatment.